Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SIP LifeLink Oncology Research Institute is a specialized biotechnology research organization located in the Suzhou Industrial Park (SIP), China. The institute focuses on the discovery and early-stage development of innovative oncology therapeutics, with a particular emphasis on precision medicine and translational research. Its activities encompass target identification, lead optimization, and the development of novel treatment modalities including small molecules and biologics. By leveraging its location in a major Chinese biotech hub, the institute collaborates with both academic and industrial partners to accelerate the transition of cancer research from the laboratory to clinical application.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SIP LifeLink Oncology Research Institute.